175 related articles for article (PubMed ID: 38426579)
1. Cytoplasmic localization of SETDB1‑induced Warburg effect via c‑MYC‑LDHA axis enhances migration and invasion in breast carcinoma.
Yang W; Wei Y; Wang T; Xu Y; Jin X; Qian H; Yang S; He S
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38426579
[TBL] [Abstract][Full Text] [Related]
2. SETDB1 induces epithelial‑mesenchymal transition in breast carcinoma by directly binding with Snail promoter.
Yang W; Su Y; Hou C; Chen L; Zhou D; Ren K; Zhou Z; Zhang R; Liu X
Oncol Rep; 2019 Feb; 41(2):1284-1292. PubMed ID: 30483750
[TBL] [Abstract][Full Text] [Related]
3. SETDB1 regulates SMAD7 expression for breast cancer metastasis.
Ryu TY; Kim K; Kim SK; Oh JH; Min JK; Jung CR; Son MY; Kim DS; Cho HS
BMB Rep; 2019 Feb; 52(2):139-144. PubMed ID: 30545440
[TBL] [Abstract][Full Text] [Related]
4. SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression.
Cao N; Yu Y; Zhu H; Chen M; Chen P; Zhuo M; Mao Y; Li L; Zhao Q; Wu M; Ye M
Cell Death Dis; 2020 May; 11(5):351. PubMed ID: 32393761
[TBL] [Abstract][Full Text] [Related]
5. Histone methyltransferase SETDB1 inhibits TGF-β-induced epithelial-mesenchymal transition in pulmonary fibrosis by regulating SNAI1 expression and the ferroptosis signaling pathway.
Liu T; Xu P; Ke S; Dong H; Zhan M; Hu Q; Li J
Arch Biochem Biophys; 2022 Jan; 715():109087. PubMed ID: 34801472
[TBL] [Abstract][Full Text] [Related]
6. SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway.
Han S; Zhen W; Guo T; Zou J; Li F
J Exp Clin Cancer Res; 2020 Oct; 39(1):218. PubMed ID: 33059737
[TBL] [Abstract][Full Text] [Related]
7. Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls
Du D; Katsuno Y; Meyer D; Budi EH; Chen SH; Koeppen H; Wang H; Akhurst RJ; Derynck R
EMBO Rep; 2018 Jan; 19(1):135-155. PubMed ID: 29233829
[TBL] [Abstract][Full Text] [Related]
8. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
[TBL] [Abstract][Full Text] [Related]
9. The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease.
Luo H; Wu X; Zhu XH; Yi X; Du D; Jiang DS
Epigenetics Chromatin; 2023 Dec; 16(1):47. PubMed ID: 38057834
[TBL] [Abstract][Full Text] [Related]
10. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1.
Zhou J; Che J; Xu L; Yang W; Li Y; Zhou W; Zou S
Bioengineered; 2022 Mar; 13(3):5737-5755. PubMed ID: 35184652
[TBL] [Abstract][Full Text] [Related]
11. CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer.
Meng X; Xiao W; Sun J; Li W; Yuan H; Yu T; Zhang X; Dong W
Cancer Lett; 2023 Feb; 554():216023. PubMed ID: 36436682
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.
Qin X; Lu M; Zhou Y; Li G; Liu Z
Cell Cycle; 2019 Apr; 18(8):889-897. PubMed ID: 30983519
[TBL] [Abstract][Full Text] [Related]
13. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
14. LINC00476 Suppresses the Progression of Non-Small Cell Lung Cancer by Inducing the Ubiquitination of SETDB1.
Cui G; Fu X; Wang W; Chen X; Liu S; Cao P; Zhao S
Radiat Res; 2021 Mar; 195(3):275-283. PubMed ID: 33370431
[TBL] [Abstract][Full Text] [Related]
15. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
[TBL] [Abstract][Full Text] [Related]
17. Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma.
Xiang J; Chen X; Chen M; Hou J
Biomed Res Int; 2022; 2022():3307873. PubMed ID: 35372573
[TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase SETDB1 promotes colorectal cancer proliferation through the STAT1-CCND1/CDK6 axis.
Yu L; Ye F; Li YY; Zhan YZ; Liu Y; Yan HM; Fang Y; Xie YW; Zhang FJ; Chen LH; Ding Y; Chen KL
Carcinogenesis; 2020 Jul; 41(5):678-688. PubMed ID: 31306481
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation.
Wu M; Fan B; Guo Q; Li Y; Chen R; Lv N; Diao Y; Luo Y
Biol Res; 2018 Oct; 51(1):39. PubMed ID: 30309377
[TBL] [Abstract][Full Text] [Related]
20. Aberrant JmjC domain-containing protein 8 (JMJD8) expression promotes activation of AKT and tumor epithelial-mesenchymal transition.
Su Y; Wang X; Guo Z; Wang J
Oncogene; 2020 Oct; 39(41):6451-6467. PubMed ID: 32879443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
